These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 15537564)
1. High-impact articles related to the pharmacotherapeutic management of systolic heart failure. Ng TM; Carter O; Guillory GS; Howard PA; Lee CR; Rodgers JE; Uber PA; Wiggins BS; Munger MA; Patterson JH Pharmacotherapy; 2004 Nov; 24(11):1594-633. PubMed ID: 15537564 [TBL] [Abstract][Full Text] [Related]
2. High-impact articles related to the management of heart failure: 2008 update. Jackevicius CA; Page RL; Chow S; Dunn SP; Lee CR; Ng TM; Rodgers JE; Vardeny O; Wiggins BS; Munger MA Pharmacotherapy; 2009 Jan; 29(1):82-120. PubMed ID: 19113799 [TBL] [Abstract][Full Text] [Related]
3. Key articles and guidelines in the management of pulmonary arterial hypertension: 2011 update. Johnson SG; Kayser SR; Attridge RL; Duvall L; Kiser TH; Moote R; Reed BN; Rodgers JE; Erstad B Pharmacotherapy; 2012 Jun; 32(6):e134-69. PubMed ID: 22467427 [TBL] [Abstract][Full Text] [Related]
4. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. Yancy CW; Lopatin M; Stevenson LW; De Marco T; Fonarow GC; J Am Coll Cardiol; 2006 Jan; 47(1):76-84. PubMed ID: 16386668 [TBL] [Abstract][Full Text] [Related]
5. Acute decompensated heart failure: best evidence and current practice. Mehta R; Feldman D Minerva Cardioangiol; 2005 Dec; 53(6):537-47. PubMed ID: 16333237 [TBL] [Abstract][Full Text] [Related]
6. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA; Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343 [TBL] [Abstract][Full Text] [Related]
7. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a scientific review. I. Introduction. Carneiro AV Rev Port Cardiol; 2008 Jun; 27(6):851-6. PubMed ID: 18751512 [TBL] [Abstract][Full Text] [Related]
8. Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure. Howard PA; Cheng JW; Crouch MA; Colucci VJ; Kalus JS; Spinler SA; Munger M Ann Pharmacother; 2006 Sep; 40(9):1607-17. PubMed ID: 16896019 [TBL] [Abstract][Full Text] [Related]
9. Systolic heart failure: chronic and acute syndromes. Chatterjee K; Rame JE Crit Care Med; 2008 Jan; 36(1 Suppl):S44-51. PubMed ID: 18158477 [TBL] [Abstract][Full Text] [Related]
10. Tezosentan in the management of decompensated heart failure. Cheng JW Cardiol Rev; 2005; 13(1):28-34. PubMed ID: 15596026 [TBL] [Abstract][Full Text] [Related]
11. Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes. Bennett KM; Hernandez AF; Chen AY; Mulgund J; Newby LK; Rumsfeld JS; Hochman JS; Hoekstra JW; Ohman EM; Gibler WB; Roe MT; Peterson ED Am J Cardiol; 2007 May; 99(10):1351-6. PubMed ID: 17493458 [TBL] [Abstract][Full Text] [Related]